TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 207 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $910,000 | +197.4% | 12,100 | +6.1% | 0.00% | +300.0% |
| Q1 2022 | $306,000 | -43.6% | 11,400 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $543,000 | -28.3% | 11,400 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $757,000 | -23.0% | 11,400 | -9.5% | 0.00% | -25.0% |
| Q2 2021 | $983,000 | -17.5% | 12,600 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,191,000 | -22.4% | 12,600 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $1,535,000 | +44.1% | 12,600 | +3.3% | 0.01% | +50.0% |
| Q3 2020 | $1,065,000 | +19.5% | 12,200 | -11.6% | 0.00% | 0.0% |
| Q2 2020 | $891,000 | +15.4% | 13,800 | -20.2% | 0.00% | 0.0% |
| Q1 2020 | $772,000 | +589.3% | 17,300 | +861.1% | 0.00% | – |
| Q4 2019 | $112,000 | -16.4% | 1,800 | -50.0% | 0.00% | – |
| Q3 2019 | $134,000 | +83.6% | 3,600 | +100.0% | 0.00% | – |
| Q2 2019 | $73,000 | – | 1,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 308,686 | $13,786,000 | 8.42% |
| Cormorant Asset Management, LP | 3,056,797 | $136,517,000 | 6.34% |
| venBio Partners LLC | 160,333 | $7,160,000 | 6.10% |
| Burrage Capital Management LLC | 77,172 | $3,250,000 | 3.20% |
| Orbimed Advisors | 2,745,327 | $122,606,000 | 2.06% |
| Parkman Healthcare Partners LLC | 80,318 | $3,587,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 117,800 | $5,261,000 | 1.01% |
| DAFNA Capital Management LLC | 46,908 | $2,095,000 | 0.87% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $1,542,000 | 0.70% |
| Nicholas Investment Partners, LP | 75,487 | $3,371,000 | 0.66% |